Article(id=1325193440664879594, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.01.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1739721600000, receivedDateStr=2025-02-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793880337157, onlineDateStr=2026-11-05, pubDate=1767974400000, pubDateStr=2026-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793880337157, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793880337157, creator=13701087609, updateTime=1793880337157, updator=13701087609, issue=Issue{id=1325193240848245724, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='1', pageStart='1', pageEnd='139', issueExtLink='null', onlineDate='null', pubDate='1767974400000', pubDateStr='2026-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793880289518, creator='13701087609', updateTime=1793935523064, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325424907554795952, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325424907554795953, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=29, endPage=41, ext={EN=ArticleExt(id=1325193441877033451, articleId=1325193440664879594, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Applications of Enzymatic Catalysis in the Synthesis of Chiral Amine Drugs, columnId=1322624444355432649, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspective & Review, runingTitle=null, highlight=null, articleAbstract=

Enzymatic catalysis, which uses enzymes as the core catalyst, has been widely applied in the synthesis of chiral drugs due to its advantages of mild reaction conditions, high stereoselectivity, and low environmental pollution.Common types of biocatalytic reactions include ketoreductase, imine reductase(IRED), transaminase(TA), hydrolase,and amino acid dehydrogenase. This paper focuses on the mechanisms of IRED and TA, as well as their applications in the synthesis of 15 marketed chiral amine drugs(with 6 cases having achieved large-scale production). It also provides an outlook on the diversified applications and future development directions of biological enzyme catalysis to address the opportunities and challenges of this technology in the future.

, authors=Xuefu YI1, Yijun ZHU2, authorsList=Xuefu YI, Yijun ZHU, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325193444376838638, articleId=1325193440664879594, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=生物酶催化在手性胺类药物合成中的应用, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

生物酶催化技术是以酶为核心进行催化反应的技术,具有反应条件温和、立体选择性高、环境污染小等优势,已广泛用于手性药物的合成。常见的生物酶催化反应类型包括酮还原酶、亚胺还原酶(IRED)、转氨酶(TA)、水解酶、氨基酸脱氢酶等。文章重点综述了IRED和TA的作用机制,及其在15例已上市手性胺类药物合成中的应用(其中6例已规模化生产应用),并展望了生物酶催化的多元化应用和未来发展方向。

, authors=衣学福1, 朱怡君2, authorsList=衣学福, 朱怡君, authorCompany=null, correspAuthors=null, authorNote=

衣学福,高级工程师,从事医药经营管理工作。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=yEOngeYheHHngsIanTrhQw==, magXml=GatYH5+TP4iQfCiMHSSLgg==, pdfUrl=null, pdf=q8GrsfmOAW3LqJ04yjZhwQ==, pdfFileSize=1753792, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=TzuGkuoG/nclxA2HOpiVQw==, mapNumber=null, fund=null)}, authors=[Author(id=1325193445211505142, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193445291196920, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445211505142, language=EN, stringName=Xuefu YI, firstName=Xuefu, middleName=null, lastName=YI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193445370888697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445211505142, language=CN, stringName=衣学福, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上药集团常州药业股份有限公司,江苏 常州 213000, bio={"content":"

衣学福,高级工程师,从事医药经营管理工作。

"}, bioImg=null, bioContent=

衣学福,高级工程师,从事医药经营管理工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193444980818415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=1., ext=[AuthorCompanyExt(id=1325193444989207024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000), AuthorCompanyExt(id=1325193444993401329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上药集团常州药业股份有限公司,江苏 常州 213000)])]), Author(id=1325193445467357691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193445559632381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445467357691, language=EN, stringName=Yijun ZHU, firstName=Yijun, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193445651907070, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445467357691, language=CN, stringName=朱怡君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.常州制药厂有限公司,江苏 常州 213018, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193445081481714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=2., ext=[AuthorCompanyExt(id=1325193445089870323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018), AuthorCompanyExt(id=1325193445098258932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.常州制药厂有限公司,江苏 常州 213018)])])], keywords=[Keyword(id=1325193445760958975, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=1, keyword=biocatalysis), Keyword(id=1325193445832262144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=2, keyword=imine reductase), Keyword(id=1325193445928731137, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=3, keyword=transaminase), Keyword(id=1325193446037783042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=4, keyword=chiral amine drug), Keyword(id=1325193446125863427, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=5, keyword=synthesis), Keyword(id=1325193446201360900, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=EN, orderNo=6, keyword=research progress), Keyword(id=1325193447887471109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=1, keyword=生物酶催化), Keyword(id=1325193448139129350, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=2, keyword=亚胺还原酶), Keyword(id=1325193448256569863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=3, keyword=转氨酶), Keyword(id=1325193448717943304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=4, keyword=手性胺类药物), Keyword(id=1325193449074459145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=5, keyword=合成), Keyword(id=1325193449175122442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1325193449862988300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MCVICKER R U, O’BOYLE N M.Chirality of new drug approvals(2013—2022): trends and perspectives [J].J Med Chem, 2024, 67(4): 2305-2320., articleTitle=null, refAbstract=null), Reference(id=1325193449967845901, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=TAMATAM R, SHIN D Y.Asymmetric synthesis of US-FDA approved drugs over five years(2016—2020): a recapitulation of chirality [J].Pharmaceuticals(Basel), 2023, 16(339):1-61., articleTitle=null, refAbstract=null), Reference(id=1325193450299195918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=朱怡君, 宦玉亮, 冷卫东, 等.叔丁基亚磺酰胺在手性胺类药物合成中的应用[J].中国医药工业杂志, 2017, 48(5):621-630., articleTitle=null, refAbstract=null), Reference(id=1325193450701849103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=REISENBAUER J C, SICINSKI KM, ARNOLD F H.Catalyzing the future: recent advances in chemical synthesis using enzymes [J].Curr Opin Chem Biol, 2024, 83: 102536., articleTitle=null, refAbstract=null), Reference(id=1325193451150639632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FRANCE S P, LEWIS R D, MARTINEZ C A.The evolving nature of biocatalysis in pharmaceutical research and development [J].JACS Au, 2023, 3(3): 715-735., articleTitle=null, refAbstract=null), Reference(id=1325193452505399826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG F, CHEN X L, XIANG C, et al.Fluorescence-based high-throughput screening system for R-ω-transaminase engineering and its substrate scope extension [J].Appl Microbiol Biot, 2020, 104(7): 2999-3009., articleTitle=null, refAbstract=null), Reference(id=1325193452622840339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=HECKMANN C M, PARADISI F.Looking back: a short history of the discovery of enzymes and how they became powerful chemical tools [J].ChemCatChem, 2020, 12(24):6082-6102., articleTitle=null, refAbstract=null), Reference(id=1325193452727697940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=汤佳伟, 陈 浩, 张露文, 等.羰基还原酶酶库的构建及其在手性醇制备中的应用[J].中国医药工业杂志, 2023,54(9): 1337-1344., articleTitle=null, refAbstract=null), Reference(id=1325193452853527061, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG C, LIU J, FANG J, et al.Ketoreductase catalyzed(dynamic) kinetic resolution for biomanufacturing of chiral chemicals [J].Front Bioeng Biotechnol, 2022, 10:929784., articleTitle=null, refAbstract=null), Reference(id=1325193452949996054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=VERMA S V, CHOUDHARY R N, KANADJE A P, et al.Diversifying arena of drug synthesis: in the realm of lipase mediated waves of biocatalysis [J].Catalysts, 2021, 11(11):1328., articleTitle=null, refAbstract=null), Reference(id=1325193453029687831, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TANG X L, WEN P F, ZHENG W, et al.Bidirectional regulation of nitrilase reaction specificity by tuning the characteristic distances between key residues and substrate[J].ACS Catal, 2023, 13: 10282-10294., articleTitle=null, refAbstract=null), Reference(id=1325193453218431512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO F, LI Y Q, MAO X M.Recent development in catalytic mechanisms and applications of microbial epoxide hydrolases[J].Synbio J, 2020, 1(5): 528-539., articleTitle=null, refAbstract=null), Reference(id=1325193453319094809, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU X S, WU Y L, ZHAN P, et al.State-of-the-art for alcohol dehydrogenase development and the prospect of its applications in bio-based furan compounds valorization [J].Synbio J, 2023, 4(6): 1122-1139., articleTitle=null, refAbstract=null), Reference(id=1325193453402980890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG L, QU X D. Application of imine reductase in the synthesis of chiral amines [J].Synbio J, 2022, 3(3): 516-529., articleTitle=null, refAbstract=null), Reference(id=1325193453486866971, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=郭 翔, 汤佳伟, 倪国伟, 等.ω-转氨酶高通量筛选方法的研究进展以及在制药工业的应用[J].中国医药工业杂志,2017, 48(4): 574-582., articleTitle=null, refAbstract=null), Reference(id=1325193453587530268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y H, CHEN F F, LI B B, et al.Stereocomplementary synthesis of pharmaceutically relevant chiral 2-aryl-substituted pyrrolidines using imine reductases [J].Org Lett, 2020,22(9): 3367-3372., articleTitle=null, refAbstract=null), Reference(id=1325193453683999261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=RODRÍGUEZ-MATA M, FRANK A, WELLS E, et al.Structure and activity of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus, which catalyses the R-selective reduction of an imine substrate [J].ChemBioChem, 2013, 14(11): 1372-1379., articleTitle=null, refAbstract=null), Reference(id=1325193453784662558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAN Z, XU Z, YU S, et al.Stereocomplementary synthesis of a key intermediate for tofacitinib via enzymatic dynamic kinetic resolution-reductive amination [J].Adv Synth Catal,2022, 364(14): 2380-2386., articleTitle=null, refAbstract=null), Reference(id=1325193453876937247, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAR R, KARMILOWICZ M J, BURKE D, et al.Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor [J].Nat Catal, 2021, 4: 775-782., articleTitle=null, refAbstract=null), Reference(id=1325193453973406240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=AFANASYEV O I, KUCHUK E, USANOV D L, et al.Reductive amination in the synthesis of pharmaceuticals [J].Chem Rev, 2019, 119(23): 11857-11911., articleTitle=null, refAbstract=null), Reference(id=1325193454078263841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=XU Z, YAO P, SHENG X, et al.Biocatalytic access to 1,4-diazepanes via imine reductase-catalyzed intramolecular asymmetric reductive amination [J].ACS Catal, 2020,10(15): 8780-8787., articleTitle=null, refAbstract=null), Reference(id=1325193454166344226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Q, LI B B, ZHANG L L, et al.Engineered imine reductase for larotrectinib intermediate manufacture [J].ACS Catalysis, 2022, 12(23): 14795-14803., articleTitle=null, refAbstract=null), Reference(id=1325193454241841699, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG A P, ZHANG X W, YANG Y M, et al.Biocatalytic synthesis of ruxolitinib intermediate via engineered imine reductase [J].J Org Chem, 2024, 89(16): 11446-11454., articleTitle=null, refAbstract=null), Reference(id=1325193454334116388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU J, YANG L, WU J, et al.Engineering imine reductase for efficient biosynthesis of 1-aryl-tetrahydro-β-carbo-lines and their N-methylation products [J].ACS Catal, 2022, 12:9823-9830., articleTitle=null, refAbstract=null), Reference(id=1325193454443168293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN X F, LI Y, XU Z F, et al.Engineered imine reductase for asymmetric synthesis of dextromethorphan key intermediate[J].Org Lett, 2024, 26(21): 4463-4468., articleTitle=null, refAbstract=null), Reference(id=1325193454518665766, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU H N, CHUANG P, XU L, et al.Asymmetric synthesis of bulky N-cyclopropylmethyl-1-aryl-1-phenylmethylamines catalyzed by engineered imine reductases [J].Org Lett,2023, 25(36): 6688-6692., articleTitle=null, refAbstract=null), Reference(id=1325193454598357543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=CITOLER J, HARAWA V, MARSHALL J R, et al.Synthesis of pharmaceutically relevant 2-aminotetralin and 3-aminochroman derivatives via enzymatic reductive amination [J].Angew Chem Int Ed Engl, 2021, 60(46):24456-24460., articleTitle=null, refAbstract=null), Reference(id=1325193454694826536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=KELLY S A, MIX S, MOODY T S, et al.Transaminases for industrial biocatalysis: novel enzyme discovery [J].Appl Microbiol Biotechnol, 2020, 104(11): 1-14., articleTitle=null, refAbstract=null), Reference(id=1325193454787101225, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=MENG Q L, RAMÍREZ-PALACIOS C, CAPRA N, et al.Computational redesign of an ω transaminase from pseudomonas jessenii for asymmetric synthesis of enantiopure bulky amines [J].ACS Catalysis, 2021, 11(17): 10733-10747., articleTitle=null, refAbstract=null), Reference(id=1325193454858404394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CUI Y M, GAO Y D, YANG L C.Transaminase catalyzed asymmetric synthesis of active pharmaceutical ingredients[J].Green Synth Catal, 2025, 6(4): 359-378., articleTitle=null, refAbstract=null), Reference(id=1325193454980039212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=VIKHRANKAR S S, SATBHAI S, KULKARNI P, et al.Enzymatic routes for chiral amine synthesis: protein engineering and process optimization [J].Biologics, 2024,18:165-179., articleTitle=null, refAbstract=null), Reference(id=1325193455068119597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=CLAUSEN A M, DZIADUL B, CAPPUCCIO K L, et al.Identification of ammonium chloride as an effective promoter of the asymmetric hydrogenation of a β-enamine amid [J].Org Process Res Dev, 2006, 10(4): 723-726., articleTitle=null, refAbstract=null), Reference(id=1325193455147811374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=SAVILE C K, JANEY J M, MUNDORFF E C, et al.Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture [J].Science, 2010,329(5989): 305-309., articleTitle=null, refAbstract=null), Reference(id=1325193455282029103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=GU X X, ZHAO J B, CHEN L, et al.Application of transition-metal catalysis, biocatalysis, and flow chemistry as state-of-the-art technologies in the synthesis of LCZ696 [J].J Org Chem, 2020, 85(11): 6844-6853., articleTitle=null, refAbstract=null), Reference(id=1325193457005888052, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=NOVICK S J, DELLAS N, GARCIA R, et al.Engineering an amine transaminase for the efficient production of a chiral sacubitril precursor [J].ACS Catalysis, 2021, 11(6): 3762-3770., articleTitle=null, refAbstract=null), Reference(id=1325193457144300085, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=LEAHY D K, FAN Y, DESAI L V, et al.Efficient and scalable enantioselective synthesis of a CGRP antagonist [J].Org Lett, 2012, 14(18): 4938-4941., articleTitle=null, refAbstract=null), Reference(id=1325193457253351990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=NOVICK Y L, JIAO X C, WANG Z J, et al.Engineering a transaminase for the effcient synthesis of a key intermediate for rimegepant [J].Org Process Res Dev, 2022, 26:1971-1977., articleTitle=null, refAbstract=null), Reference(id=1325193457337238071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=YASUDA N, CLEATOR E, KOSJEK B, et al.Practical asymmetric synthesis of a calcitonin gene-related peptide(CGRP) receptor antagonist ubrogepant [J].Org Process Res Dev, 2017, 21(11): 1851-1858., articleTitle=null, refAbstract=null), Reference(id=1325193457437901368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUNG C K, BULGER P G, BELYK K M, et al.Process development of C-N cross-coupling and enantioselective biocatalytic reactions for the asymmetric synthesis of niraparib[J].Org Process Res Dev, 2014, 18(1): 215-227., articleTitle=null, refAbstract=null), Reference(id=1325193457530176057, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=BULLER R, LUTZ S, KAZLAUSKAS R J, et al.From nature to industry: harnessing enzymes for biocatalysis [J].Science, 2023, 382(6673): eadh8615., articleTitle=null, refAbstract=null), Reference(id=1325193457618256442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=胡 畔, 吴小凡, 黄则度, 等.固定化羰基还原酶在连续流合成中的研究进展[J].中国医药工业杂志, 2024, 55(12):421-434., articleTitle=null, refAbstract=null), Reference(id=1325193457706336827, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=O’CONNELL A, BARRY A, BURKE A J, et al.Biocatalysis:landmark discoveries and applications in chemical synthesis[J].Chem Soc Rev, 2024, 53(6): 2828-2850., articleTitle=null, refAbstract=null), Reference(id=1325193457815388732, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=BENÍTEZ-MATEOS A I, PADROSA D R, PARADISI F, et al.Multistep enzyme cascades as a route towards green and sustainable pharmaceutical syntheses [J].Nat Chem, 2022,14(5): 489-499., articleTitle=null, refAbstract=null), Reference(id=1325193457911857725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG M, CHEN B, HUANG X Q.Recent advances in photoenzymatic synthesis [J].Synth Biol J, 2023, 4(4): 651-675., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325193449493889547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, awardId=CF20240088, language=CN, fundingSource=常州市科技计划项目(CF20240088), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325193444980818415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=1., ext=[AuthorCompanyExt(id=1325193444989207024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000), AuthorCompanyExt(id=1325193444993401329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上药集团常州药业股份有限公司,江苏 常州 213000)]), AuthorCompany(id=1325193445081481714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=2., ext=[AuthorCompanyExt(id=1325193445089870323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018), AuthorCompanyExt(id=1325193445098258932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.常州制药厂有限公司,江苏 常州 213018)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.01.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.01.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.01.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.01.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1767974400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
生物酶催化在手性胺类药物合成中的应用
衣学福 1 , 朱怡君 2
中国医药工业杂志 | 专论与综述 2026,57(1): 29-41
收起
收藏切换
中国医药工业杂志 |专论与综述 2026 , 57 (1) : 29 -41
生物酶催化在手性胺类药物合成中的应用
全屏
[Author(id=1325193445211505142, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193445291196920, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445211505142, language=EN, stringName=Xuefu YI, firstName=Xuefu, middleName=null, lastName=YI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193445370888697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445211505142, language=CN, stringName=衣学福, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上药集团常州药业股份有限公司,江苏 常州 213000, bio={"content":"

衣学福,高级工程师,从事医药经营管理工作。

"}, bioImg=null, bioContent=

衣学福,高级工程师,从事医药经营管理工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193444980818415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=1., ext=[AuthorCompanyExt(id=1325193444989207024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000), AuthorCompanyExt(id=1325193444993401329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193444980818415, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上药集团常州药业股份有限公司,江苏 常州 213000)])]), Author(id=1325193445467357691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193445559632381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445467357691, language=EN, stringName=Yijun ZHU, firstName=Yijun, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193445651907070, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, authorId=1325193445467357691, language=CN, stringName=朱怡君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.常州制药厂有限公司,江苏 常州 213018, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193445081481714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, xref=2., ext=[AuthorCompanyExt(id=1325193445089870323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018), AuthorCompanyExt(id=1325193445098258932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193440664879594, companyId=1325193445081481714, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.常州制药厂有限公司,江苏 常州 213018)])])]
衣学福1, 朱怡君2
作者信息
  • 1.上药集团常州药业股份有限公司,江苏 常州 213000
  • 2.常州制药厂有限公司,江苏 常州 213018
作者简介:

衣学福,高级工程师,从事医药经营管理工作。

Applications of Enzymatic Catalysis in the Synthesis of Chiral Amine Drugs
Xuefu YI1, Yijun ZHU2
Affiliations
  • 1.SPH Changzhou Pharmaceutical Co., Ltd., Changzhou 213000
  • 2.Changzhou Pharmaceutical Factory Co., Ltd., Changzhou 213018
出版时间: 2026-01-10 doi: 10.16522/j.cnki.cjph.2026.01.002
文章导航
收藏切换

生物酶催化技术是以酶为核心进行催化反应的技术,具有反应条件温和、立体选择性高、环境污染小等优势,已广泛用于手性药物的合成。常见的生物酶催化反应类型包括酮还原酶、亚胺还原酶(IRED)、转氨酶(TA)、水解酶、氨基酸脱氢酶等。文章重点综述了IRED和TA的作用机制,及其在15例已上市手性胺类药物合成中的应用(其中6例已规模化生产应用),并展望了生物酶催化的多元化应用和未来发展方向。

生物酶催化  /  亚胺还原酶  /  转氨酶  /  手性胺类药物  /  合成  /  研究进展

Enzymatic catalysis, which uses enzymes as the core catalyst, has been widely applied in the synthesis of chiral drugs due to its advantages of mild reaction conditions, high stereoselectivity, and low environmental pollution.Common types of biocatalytic reactions include ketoreductase, imine reductase(IRED), transaminase(TA), hydrolase,and amino acid dehydrogenase. This paper focuses on the mechanisms of IRED and TA, as well as their applications in the synthesis of 15 marketed chiral amine drugs(with 6 cases having achieved large-scale production). It also provides an outlook on the diversified applications and future development directions of biological enzyme catalysis to address the opportunities and challenges of this technology in the future.

biocatalysis  /  imine reductase  /  transaminase  /  chiral amine drug  /  synthesis  /  research progress
衣学福, 朱怡君. 生物酶催化在手性胺类药物合成中的应用. 中国医药工业杂志, 2026 , 57 (1) : 29 -41 . DOI: 10.16522/j.cnki.cjph.2026.01.002
Xuefu YI, Yijun ZHU. Applications of Enzymatic Catalysis in the Synthesis of Chiral Amine Drugs[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (1) : 29 -41 . DOI: 10.16522/j.cnki.cjph.2026.01.002
  • 常州市科技计划项目(CF20240088)
参考文献 引证文献
排序方式:
[1]
MCVICKER R U, O’BOYLE N M.Chirality of new drug approvals(2013—2022): trends and perspectives [J].J Med Chem, 2024, 67(4): 2305-2320.
[2]
TAMATAM R, SHIN D Y.Asymmetric synthesis of US-FDA approved drugs over five years(2016—2020): a recapitulation of chirality [J].Pharmaceuticals(Basel), 2023, 16(339):1-61.
[3]
朱怡君, 宦玉亮, 冷卫东, 等.叔丁基亚磺酰胺在手性胺类药物合成中的应用[J].中国医药工业杂志, 2017, 48(5):621-630.
[4]
REISENBAUER J C, SICINSKI KM, ARNOLD F H.Catalyzing the future: recent advances in chemical synthesis using enzymes [J].Curr Opin Chem Biol, 2024, 83: 102536.
[5]
FRANCE S P, LEWIS R D, MARTINEZ C A.The evolving nature of biocatalysis in pharmaceutical research and development [J].JACS Au, 2023, 3(3): 715-735.
[6]
CHENG F, CHEN X L, XIANG C, et al.Fluorescence-based high-throughput screening system for R-ω-transaminase engineering and its substrate scope extension [J].Appl Microbiol Biot, 2020, 104(7): 2999-3009.
[7]
HECKMANN C M, PARADISI F.Looking back: a short history of the discovery of enzymes and how they became powerful chemical tools [J].ChemCatChem, 2020, 12(24):6082-6102.
[8]
汤佳伟, 陈 浩, 张露文, 等.羰基还原酶酶库的构建及其在手性醇制备中的应用[J].中国医药工业杂志, 2023,54(9): 1337-1344.
[9]
HUANG C, LIU J, FANG J, et al.Ketoreductase catalyzed(dynamic) kinetic resolution for biomanufacturing of chiral chemicals [J].Front Bioeng Biotechnol, 2022, 10:929784.
[10]
VERMA S V, CHOUDHARY R N, KANADJE A P, et al.Diversifying arena of drug synthesis: in the realm of lipase mediated waves of biocatalysis [J].Catalysts, 2021, 11(11):1328.
[11]
TANG X L, WEN P F, ZHENG W, et al.Bidirectional regulation of nitrilase reaction specificity by tuning the characteristic distances between key residues and substrate[J].ACS Catal, 2023, 13: 10282-10294.
[12]
CAO F, LI Y Q, MAO X M.Recent development in catalytic mechanisms and applications of microbial epoxide hydrolases[J].Synbio J, 2020, 1(5): 528-539.
[13]
LIU X S, WU Y L, ZHAN P, et al.State-of-the-art for alcohol dehydrogenase development and the prospect of its applications in bio-based furan compounds valorization [J].Synbio J, 2023, 4(6): 1122-1139.
[14]
YANG L, QU X D. Application of imine reductase in the synthesis of chiral amines [J].Synbio J, 2022, 3(3): 516-529.
[15]
郭 翔, 汤佳伟, 倪国伟, 等.ω-转氨酶高通量筛选方法的研究进展以及在制药工业的应用[J].中国医药工业杂志,2017, 48(4): 574-582.
[16]
ZHANG Y H, CHEN F F, LI B B, et al.Stereocomplementary synthesis of pharmaceutically relevant chiral 2-aryl-substituted pyrrolidines using imine reductases [J].Org Lett, 2020,22(9): 3367-3372.
[17]
RODRÍGUEZ-MATA M, FRANK A, WELLS E, et al.Structure and activity of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus, which catalyses the R-selective reduction of an imine substrate [J].ChemBioChem, 2013, 14(11): 1372-1379.
[18]
ZHAN Z, XU Z, YU S, et al.Stereocomplementary synthesis of a key intermediate for tofacitinib via enzymatic dynamic kinetic resolution-reductive amination [J].Adv Synth Catal,2022, 364(14): 2380-2386.
[19]
KUMAR R, KARMILOWICZ M J, BURKE D, et al.Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor [J].Nat Catal, 2021, 4: 775-782.
[20]
AFANASYEV O I, KUCHUK E, USANOV D L, et al.Reductive amination in the synthesis of pharmaceuticals [J].Chem Rev, 2019, 119(23): 11857-11911.
[21]
XU Z, YAO P, SHENG X, et al.Biocatalytic access to 1,4-diazepanes via imine reductase-catalyzed intramolecular asymmetric reductive amination [J].ACS Catal, 2020,10(15): 8780-8787.
[22]
CHEN Q, LI B B, ZHANG L L, et al.Engineered imine reductase for larotrectinib intermediate manufacture [J].ACS Catalysis, 2022, 12(23): 14795-14803.
[23]
HUANG A P, ZHANG X W, YANG Y M, et al.Biocatalytic synthesis of ruxolitinib intermediate via engineered imine reductase [J].J Org Chem, 2024, 89(16): 11446-11454.
[24]
ZHU J, YANG L, WU J, et al.Engineering imine reductase for efficient biosynthesis of 1-aryl-tetrahydro-β-carbo-lines and their N-methylation products [J].ACS Catal, 2022, 12:9823-9830.
[25]
LIN X F, LI Y, XU Z F, et al.Engineered imine reductase for asymmetric synthesis of dextromethorphan key intermediate[J].Org Lett, 2024, 26(21): 4463-4468.
[26]
ZHOU H N, CHUANG P, XU L, et al.Asymmetric synthesis of bulky N-cyclopropylmethyl-1-aryl-1-phenylmethylamines catalyzed by engineered imine reductases [J].Org Lett,2023, 25(36): 6688-6692.
[27]
CITOLER J, HARAWA V, MARSHALL J R, et al.Synthesis of pharmaceutically relevant 2-aminotetralin and 3-aminochroman derivatives via enzymatic reductive amination [J].Angew Chem Int Ed Engl, 2021, 60(46):24456-24460.
[28]
KELLY S A, MIX S, MOODY T S, et al.Transaminases for industrial biocatalysis: novel enzyme discovery [J].Appl Microbiol Biotechnol, 2020, 104(11): 1-14.
[29]
MENG Q L, RAMÍREZ-PALACIOS C, CAPRA N, et al.Computational redesign of an ω transaminase from pseudomonas jessenii for asymmetric synthesis of enantiopure bulky amines [J].ACS Catalysis, 2021, 11(17): 10733-10747.
[30]
CUI Y M, GAO Y D, YANG L C.Transaminase catalyzed asymmetric synthesis of active pharmaceutical ingredients[J].Green Synth Catal, 2025, 6(4): 359-378.
[31]
VIKHRANKAR S S, SATBHAI S, KULKARNI P, et al.Enzymatic routes for chiral amine synthesis: protein engineering and process optimization [J].Biologics, 2024,18:165-179.
[32]
CLAUSEN A M, DZIADUL B, CAPPUCCIO K L, et al.Identification of ammonium chloride as an effective promoter of the asymmetric hydrogenation of a β-enamine amid [J].Org Process Res Dev, 2006, 10(4): 723-726.
[33]
SAVILE C K, JANEY J M, MUNDORFF E C, et al.Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture [J].Science, 2010,329(5989): 305-309.
[34]
GU X X, ZHAO J B, CHEN L, et al.Application of transition-metal catalysis, biocatalysis, and flow chemistry as state-of-the-art technologies in the synthesis of LCZ696 [J].J Org Chem, 2020, 85(11): 6844-6853.
[35]
NOVICK S J, DELLAS N, GARCIA R, et al.Engineering an amine transaminase for the efficient production of a chiral sacubitril precursor [J].ACS Catalysis, 2021, 11(6): 3762-3770.
[36]
LEAHY D K, FAN Y, DESAI L V, et al.Efficient and scalable enantioselective synthesis of a CGRP antagonist [J].Org Lett, 2012, 14(18): 4938-4941.
[37]
NOVICK Y L, JIAO X C, WANG Z J, et al.Engineering a transaminase for the effcient synthesis of a key intermediate for rimegepant [J].Org Process Res Dev, 2022, 26:1971-1977.
[38]
YASUDA N, CLEATOR E, KOSJEK B, et al.Practical asymmetric synthesis of a calcitonin gene-related peptide(CGRP) receptor antagonist ubrogepant [J].Org Process Res Dev, 2017, 21(11): 1851-1858.
[39]
CHUNG C K, BULGER P G, BELYK K M, et al.Process development of C-N cross-coupling and enantioselective biocatalytic reactions for the asymmetric synthesis of niraparib[J].Org Process Res Dev, 2014, 18(1): 215-227.
[40]
BULLER R, LUTZ S, KAZLAUSKAS R J, et al.From nature to industry: harnessing enzymes for biocatalysis [J].Science, 2023, 382(6673): eadh8615.
[41]
胡 畔, 吴小凡, 黄则度, 等.固定化羰基还原酶在连续流合成中的研究进展[J].中国医药工业杂志, 2024, 55(12):421-434.
[42]
O’CONNELL A, BARRY A, BURKE A J, et al.Biocatalysis:landmark discoveries and applications in chemical synthesis[J].Chem Soc Rev, 2024, 53(6): 2828-2850.
[43]
BENÍTEZ-MATEOS A I, PADROSA D R, PARADISI F, et al.Multistep enzyme cascades as a route towards green and sustainable pharmaceutical syntheses [J].Nat Chem, 2022,14(5): 489-499.
[44]
YANG M, CHEN B, HUANG X Q.Recent advances in photoenzymatic synthesis [J].Synth Biol J, 2023, 4(4): 651-675.
2026年第57卷第1期
144
36
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.01.002
  • 接收时间:2025-02-17
  • 首发时间:2026-11-05
  • 出版时间:2026-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-02-17
基金
常州市科技计划项目(CF20240088)
作者信息
    1.上药集团常州药业股份有限公司,江苏 常州 213000
    2.常州制药厂有限公司,江苏 常州 213018
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.01.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏